Teikyo University · International Education Research Institute · 講師

Research keywordsnon-small cell lung cancer・thoracic chemoradiotherapy・durvalumab consolidation・EGFR-mutant NSCLC・lung squamous cell carcinoma・thoracic oncology・bevacizumab-based chemotherapy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
• A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.
• Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial.
• Importance and difficulty of differentiating BMA-induced AFF prodromal symptoms from hormonal therapy-related femoral pain

• Official profile